Wed, September 18, 2024
Tue, September 17, 2024
Mon, September 16, 2024
Fri, September 13, 2024
Thu, September 12, 2024

Charles Duncan Reiterated (AXSM) at Buy and Held Target at $107 on, Sep 16th, 2024


//stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-107-on-sep-16th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy and Held Target at $107 on, Sep 16th, 2024.

Charles has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Charles


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $130 on, Thursday, September 5th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $180 on, Thursday, September 5th, 2024
  • Cerena Chen of "Wells Fargo" Initiated at Buy and Held Target at $140 on, Tuesday, September 3rd, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $105 on, Tuesday, August 6th, 2024
  • Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $106 on, Tuesday, August 6th, 2024
  • Leonid Timashev of "RBC Capital" Maintained at Buy with Decreased Target to $130 on, Tuesday, August 6th, 2024
  • Graig Suvannavejh of "Mizuho" Reiterated at Strong Buy and Held Target at $106 on, Wednesday, June 12th, 2024

Publication Contributing Sources